Literature DB >> 1426260

Gelation of liposome interior. A novel method for drug encapsulation.

D D Lasic1, P M Frederik, M C Stuart, Y Barenholz, T J McIntosh.   

Abstract

Liposomes can be loaded with weak acids and bases, which exist in solutions in equilibrium with membrane permeable uncharged form, using various gradients across their membranes. Because in some cases the estimated drug concentration in the loaded liposomes exceeds their aqueous solubility we investigated the physical state of the liposome encapsulated anticancer drug Doxorubicin. X-Ray diffraction, electron microscopy, and test tube solubility experiments have shown that upon encapsulation the drug molecules form a gel-like phase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426260     DOI: 10.1016/0014-5793(92)80947-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  46 in total

1.  Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes.

Authors:  S Bandak; A Ramu; Y Barenholz; A Gabizon
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Targeted nanogels: a versatile platform for drug delivery to tumors.

Authors:  Eric A Murphy; Bharat K Majeti; Rajesh Mukthavaram; Lisette M Acevedo; Leo A Barnes; David A Cheresh
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

3.  Protein encapsulation in unilamellar liposomes: high encapsulation efficiency and a novel technique to assess lipid-protein interaction.

Authors:  Xiaoming Xu; Antonio Costa; Diane J Burgess
Journal:  Pharm Res       Date:  2012-03-09       Impact factor: 4.200

4.  Pharmacokinetics and antitumor effect of doxorubicin carried by stealth and remote loading proliposome.

Authors:  J P Wang; Y Maitani; K Takayama; T Nagai
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

5.  Inhibition of tracheal vascular extravasation by liposome-encapsulated albuterol in rats.

Authors:  W Zhang; L Guo; J A Nadel; D Papahadjopoulos
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

6.  Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics.

Authors:  Junhwa Shin; Pochi Shum; Jessica Grey; Shin-ichi Fujiwara; Guarov S Malhotra; Andres González-Bonet; Seok-Hee Hyun; Elaine Moase; Theresa M Allen; David H Thompson
Journal:  Mol Pharm       Date:  2012-10-03       Impact factor: 4.939

7.  Development of anti-p185HER2 immunoliposomes for cancer therapy.

Authors:  J W Park; K Hong; P Carter; H Asgari; L Y Guo; G A Keller; C Wirth; R Shalaby; C Kotts; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes.

Authors:  Eric E Paoli; Elizabeth S Ingham; Hua Zhang; Lisa M Mahakian; Brett Z Fite; M Karen Gagnon; Sarah Tam; Azadeh Kheirolomoom; Robert D Cardiff; Katherine W Ferrara
Journal:  J Control Release       Date:  2014-01-13       Impact factor: 9.776

Review 9.  Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

Authors:  Alberto Gabizon; Hilary Shmeeda; Yechezkel Barenholz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine.

Authors:  Charles O Noble; Zexiong Guo; Mark E Hayes; James D Marks; John W Park; Christopher C Benz; Dmitri B Kirpotin; Daryl C Drummond
Journal:  Cancer Chemother Pharmacol       Date:  2009-01-30       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.